(Q58645594)

English

Atrial fibrillation

No description defined

In more languages

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Atrial fibrillation (English)

0 references

atrial fibrillation

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27159789%20AND%20SRC:MED&resulttype=core&format=json

26 May 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27159789%20AND%20SRC:MED&resulttype=core&format=json

26 May 2020

Michiel Rienstra

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27159789%20AND%20SRC:MED&resulttype=core&format=json

26 May 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27159789%20AND%20SRC:MED&resulttype=core&format=json

26 May 2020

5

object named as

Andrea Natale

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27159789%20AND%20SRC:MED&resulttype=core&format=json

26 May 2020

1

object named as

Gregory Y H Lip

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27159789%20AND%20SRC:MED&resulttype=core&format=json

26 May 2020

Tatjana S Potpara

8

object named as

Tatjana Potpara

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27159789%20AND%20SRC:MED&resulttype=core&format=json

26 May 2020

11

object named as

Deirdre A Lane

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27159789%20AND%20SRC:MED&resulttype=core&format=json

26 May 2020

Laurent Fauchier

2

object named as

Laurent Fauchier

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27159789%20AND%20SRC:MED&resulttype=core&format=json

26 May 2020

Isabelle C Van Gelder

4

object named as

Isabelle Van Gelder

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27159789%20AND%20SRC:MED&resulttype=core&format=json

26 May 2020

author name string

Carola Gianni

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27159789%20AND%20SRC:MED&resulttype=core&format=json

26 May 2020

publication date

31 March 2016

0 references

Nature Reviews Disease Primers

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27159789%20AND%20SRC:MED&resulttype=core&format=json

26 May 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27159789%20AND%20SRC:MED&resulttype=core&format=json

26 May 2020

1

0 references

16016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27159789%20AND%20SRC:MED&resulttype=core&format=json

26 May 2020

https://scigraph.springernature.com/pub.10.1038/nrdp.2016.16

0 references

The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Incident atrial fibrillation among Asians, Hispanics, blacks, and whites

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Global epidemiology of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Atrial fibrillation in patients with cryptogenic stroke.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Cognitive impairment associated with atrial fibrillation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

New ideas about atrial fibrillation 50 years on.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Recent advances in the molecular pathophysiology of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Of circles and spirals: bridging the gap between the leading circle and spiral wave concepts of cardiac reentry

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Mechanisms of atrial fibrillation termination by pure sodium channel blockade in an ionically-realistic mathematical model.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Attraction of rotors to the pulmonary veins in paroxysmal atrial fibrillation: a modeling study.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Paroxysmal atrial fibrillation and pulmonary veins: relationships between clinical forms and automatic versus re-entrant mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Atrial fibrillation driven by micro-anatomic intramural re-entry revealed by simultaneous sub-epicardial and sub-endocardial optical mapping in explanted human hearts.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Atrial fibrillation pathophysiology: implications for management.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Atrial fibrillation ablation: translating basic mechanistic insights to the patient.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY).

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

New directions in cardiac arrhythmia management: present challenges and future solutions.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

High prevalence of atrial fibrillation among patients with ischemic stroke.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Adelaide stroke incidence study: declining stroke rates but many preventable cardioembolic strokes

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Comparison of the Microlife blood pressure monitor with the Omron blood pressure monitor for detecting atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

A novel application for the detection of an irregular pulse using an iPhone 4S in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Screening to identify unknown atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Asymptomatic Atrial Fibrillation: The Case for Screening to Prevent Stroke.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Rhythm-symptom correlation in patients on continuous monitoring after catheter ablation of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Symptomatic and asymptomatic long-term recurrences following transcatheter atrial fibrillation ablation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Cryptogenic stroke and underlying atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Heart-rhythm monitoring for evaluation of cryptogenic stroke.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Frequency, duration, and predictors of newly-diagnosed atrial fibrillation following dual-chamber pacemaker implantation in patients without a previous history of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices).

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Clinical significance of atrial fibrillation detected by cardiac implantable electronic devices

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Device-detected atrial fibrillation: what to do with asymptomatic patients?

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Atrial Fibrillation Burden and Short-Term Risk of Stroke: Case-Crossover Analysis of Continuously Recorded Heart Rhythm From Cardiac Electronic Implanted Devices.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Temporal relationship between subclinical atrial fibrillation and embolic events

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Controlling acute rheumatic fever and rheumatic heart disease in developing countries: are we getting closer?

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

A cost-effectiveness analysis of a program to control rheumatic fever and rheumatic heart disease in Pinar del Rio, Cuba

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Obesity and the Risk of New-Onset Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study)

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Alcohol Consumption and Risk of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Severe obesity and P-wave dispersion: the effect of surgically induced weight loss

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Beyond the guidelines: new and novel agents for the prevention of atrial fibrillation after cardiothoracic surgery

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

The role of statin therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on risk of atrial fibrillation before coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Efficacy of different statins for primary prevention of atrial fibrillation in male and female patients: a nationwide population-based cohort study.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Stroke prevention in atrial fibrillation: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Stroke severity in atrial fibrillation. The Framingham Study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Stroke and thromboembolism in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe?

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Assessment of stroke risk in Middle Eastern patients with atrial fibrillation: the Gulf SAFE registry

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation: A Nationwide Cohort Study From Taiwan

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant: using the SAMe-TT2R2 score.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Apixaban in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Gro

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Lenient versus strict rate control in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Rate-control treatment and mortality in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

An individual patient-based meta-analysis of the effects of dronedarone in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Interaction between digoxin and dronedarone in the PALLAS trial

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Factors predisposing to ventricular proarrhythmia during antiarrhythmic drug therapy for atrial fibrillation in patients with structurally normal heart.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Effect of periprocedural amiodarone on procedure outcome in patients with longstanding persistent atrial fibrillation undergoing extended pulmonary vein antrum isolation: results from a randomized study (SPECULATE).

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Human electrophysiological and pharmacological properties of XEN-D0101: a novel atrial-selective Kv1.5/IKur inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Atrial-selective prolongation of refractory period with AVE0118 is due principally to inhibition of sodium channel activity

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Antiarrhythmic properties of ranolazine: A review of the current evidence.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythm.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Pulmonary vein antrum isolation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Development of the human pulmonary vein and its incorporation in the morphologically left atrium

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Venice Chart international consensus document on atrial fibrillation ablation: 2011 update

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Comparison of radiofrequency catheter ablation of drivers and circumferential pulmonary vein isolation in atrial fibrillation: a noninferiority randomized multicenter RADAR-AF trial.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Approaches to catheter ablation for persistent atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Pulmonary vein isolation using a visually guided laser balloon catheter: the first 200-patient multicenter clinical experience

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Robotic magnetic navigation for atrial fibrillation ablation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Atrial fibrillation ablation using a robotic catheter remote control system: initial human experience and long-term follow-up results.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Ablation of persistent atrial fibrillation using multielectrode catheters and duty-cycled radiofrequency energy.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Catheter ablation of atrial fibrillation: an update

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Complications of atrial fibrillation ablation: when prevention is better than cure.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design:

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Quality of life in patients with atrial fibrillation: how to assess it and how to improve it.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Quality of life in patients with atrial fibrillation: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Effects of pharmacologic therapy on health-related quality of life in elderly patients with atrial fibrillation: a systematic review of randomized and nonrandomized trials.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: etiology and initial investigations

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Interpreting changes in quality of life in atrial fibrillation: how much change is meaningful?

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillatio

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Favorable long-term outcome of Maze surgery in patients with lone atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Patients' perspectives on taking warfarin: qualitative study in family practice

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

The impact of long-term warfarin on the quality of life of elderly people with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Early management of atrial fibrillation to prevent cardiovascular complications

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Atrial remodeling, fibrosis, and atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Catheter ablation of atrial arrhythmias: state of the art.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Catheter ablation of atrial fibrillation: how to modify the substrate?

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Contemporary challenges of catheter ablation for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Non-invasive imaging in atrial fibrillation: focus on prognosis and catheter ablation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Embolic strokes of undetermined source: the case for a new clinical construct

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Non-valvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Dabigatran versus warfarin in patients with mechanical heart valves

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

A six-item short-form survey for measuring headache impact: the HIT-6.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL).

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Validating a new quality of life questionnaire for atrial fibrillation patients

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Incidence and risk of atrial fibrillation in sleep-disordered breathing without coexistent systemic disease.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

The association between hyperuricemia, left atrial size and new-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women--the Tromso Study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study).

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Obesity results in progressive atrial structural and electrical remodeling: Implications for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Left Atrial Appendage

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

21 January 2018

Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

African american race and prevalence of atrial fibrillation:a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Atrial fibrillation amongst the Indo-Asian general practice population. The West Birmingham Atrial Fibrillation Project

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Epidemiology of valvular heart disease in the adult

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Driver Domains in Persistent Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Connexins and atrial fibrillation: filling in the gaps

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Atrial ischemia promotes atrial fibrillation in dogs

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Mechanisms of atrial tachyarrhythmias associated with coronary artery occlusion in a chronic canine model

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Hypertension and atrial fibrillation: evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Self-monitoring for atrial fibrillation recurrence in the discharge period post-cardiac surgery using an iPhone electrocardiogram

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Subclinical Atrial Fibrillation and the Risk of Stroke

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Atrial fibrillation and obesity--results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Atrial fibrillation in athletes and the interplay between exercise and health

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

The role of aspirin for stroke prevention in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Modern management of atrial fibrillation requires initial identification of "low-risk" patients using the CHA2DS2-VASc score, and not focusing on "high-risk" prediction

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

The risks of risk scores for stroke risk assessment in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex)

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Rate control in atrial fibrillation: many questions still unanswered

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Oral anticoagulation in atrial fibrillation: A pan-European patient survey

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Consistency of safety profile of new oral anticoagulants in patients with renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Obstructive sleep apnea and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.16

31 March 2020

Identifiers

10.1038/NRDP.2016.16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27159789%20AND%20SRC:MED&resulttype=core&format=json

26 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27159789%20AND%20SRC:MED&resulttype=core&format=json

26 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58645594&oldid=1999265682"